Skip to content
Wenlo
Sign in
← Markets

Lexeo Therapeutics, Inc.

Lexeo Therapeutics, Inc. (LXEO) — Form 144: Proposed sale of shares

144LXEOFiled Nov 17, 2026, 10:34 AM ET

About this filing

Lexeo Therapeutics, Inc. (LXEO) filed Form 144 (proposed sale of shares) with the SEC on Nov 17, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.

Key facts

Seller
Tamayo Louis Edward
Relationship
Officer
Shares to sell
1,007
Market value
$3,279.40
Approximate sale date
Nov 17, 2026
Broker
Fidelity Brokerage Services LLC
Acquired
Nov 16, 2026 · Restricted Stock Vesting
Remarks
  1. Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.

More LXEO filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.